ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc (CRVS)

4.69
0.31
( 7.08% )
Updated: 13:37:20

Corvus Pharmaceuticals Inc Financial Summary

The current CRVS market cap is 301.37M. The company's latest EPS is USD -0.4206 and P/E is -11.17.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -6.43M-7.06M-6.25M-6.28M-7.94M
Net Income -6M-6.65M-5.7M-4.26M-40.22M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -48.85M-43.99M-43.46M-42.57M-28.69M
Net Income -46.67M-6M-43.24M-41.31M-27.03M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 51.94M45.55M40.08M64.56M58.82M
Total Liabilities 7.65M6.87M6.72M13.34M46.41M
Total Equity 44.29M38.68M33.36M51.23M12.41M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 83.65M85.53M109.46M68.24M45.55M
Total Liabilities 12.54M13.38M12.29M12.13M6.87M
Total Equity 71.11M72.15M97.16M56.12M38.68M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -18.77M-23.94M-5.16M-10.64M-16.96M
Investing 17.86M15.54M-7k-17.51M-21.4M
Financing 7.86M7.86M N/A 30.37M30.42M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -37.32M-34.78M-36.72M-27.02M-23.94M
Investing 3.26M44.77M21.56M-23.28M15.54M
Financing 24k1.31M62.16M N/A 7.86M
Market Cap 301.37M
Price to Earnings Ratio -11.17
Price to Sales Ratio 0
Price to Cash Ratio 23.93
Price to Book Ratio 7.81
Dividend Yield -

Share Statistics

Shares Outstanding 64.26M
Average Volume (1 week) 652.81k
Average Volume (1 Month) 616.8k
52 Week Change 116.13%
52 Week High 10.00
52 Week Low 1.30
Spread (Intraday) 0.01 (0.21%)

Company Info

Company Name Corvus Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.corvuspharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock